Lotesol 2 Eye Drop contains Loteprednol etabonate 0.2% w/v, a corticosteroid specifically formulated for ophthalmic use. It is indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation following ocular surgery, and anterior uveitis. Loteprednol etabonate exerts its anti-inflammatory effects by inhibiting the release of inflammatory mediators, thereby reducing ocular redness, swelling, and discomfort. The formulation is designed to provide effective local therapy with minimal systemic absorption, reducing the risk of systemic corticosteroid-related side effects. Lotesol 2 Eye Drop is typically administered as one or two drops in the affected eye(s) two to four times daily, with dosage adjustments based on clinical response and severity of the condition. Patients should use the medication under the supervision of an ophthalmologist, and prolonged use should be avoided to minimize potential adverse effects such as increased intraocular pressure, cataract formation, or secondary infections. It is contraindicated in viral, fungal, or mycobacterial ocular infections. Caution is advised in patients with glaucoma or a history of steroid responsiveness. Proper administration technique and adherence to prescribed dosage are essential for optimal therapeutic outcomes.